rediff.com

NewsApp (Free)

Read news as it happens
Download NewsApp

Available on  

Rediff News  All News 

Sarabjit Kour Nangra

Rediff.com  »  News  »   Sarabjit Kour Nangra

  News for Sarabjit Kour Nangra

  • Business

Drugs of 7 Indian pharma firms in EMA's suspension list

Several drugs manufactured and marketed by as many as seven Indian generic pharmaceutical companies have been recommended for suspension by the European Medicines Agency (EMA) in its orders issued......

Rouble fall to impact Indian pharma exports

Though the fall in the Russian currency means earning of more roubles, the actual value of revenue will be determined only in correlation with the dollar and the rupee, according to him. The......

TCS shares slump over 9%, mcap down Rs 46,000 cr

Shares of IT bellwether TCS on Friday tumbled over 9 per cent, eroding Rs 45,824 crore from its market valuation, after its September quarter numbers failed to meet market expectations. The scrip......

Pharma stocks could rise another 15-20%

The pharmaceutical sector has been one of the highest sectoral gainers in recent weeks, with six of the top 10 stocks by market capitalisation touching their all-time highs in July. Expectations......

Ranbaxy suspends shipments from 2 plants; shares down over 2%

Shares of Ranbaxy Ltd on Tuesday fell over 2 per cent on the bourses after the company said it has suspended shipments of all pharmaceutical ingredients from its Tonsa and Dewas plants. "This......
  Web results for Sarabjit Kour Nangra
Street undeterred by USFDA observations on Lupin's Indore plant

Lupin has been in the midst of news flow. While last week it announced developments on two respiratory products, on Monday it received final... ...

http://wap.business-standard.com/article/opinion/compass-street-undeterred-by-usfda-observations-on-lupins-indore-plant-115022401020_1.html
Infy to buy Panaya for $200m

Mumbai, Feb. 16: Infosys will acquire US-based automation technology company Panaya for $200 million (over Rs 1,200 crore). The all-cash deal is... ...

http://www.telegraphindia.com/1150217/jsp/business/story_3756.jsp
Hard days for software exports

Mumbai,Feb. 10: IT-BPO exports are likely to grow at 12-14 per cent in the next fiscal, industry body Nasscom said today. The growth rate is lower... ...

http://www.telegraphindia.com/1150211/jsp/business/story_2651.jsp
Angel Broking recommends long term buy on Infosys, TCS and Wipro

According to Nasscom, revenues for IT sector are expected to grow at 13% in FY2015 to end the year, USD 146 billion. The revenue growth rate target... ...

http://www.myiris.com/news/livenews/angel-broking-recommends-long-term-buy-on-infosys-tcs-and-wipro/20150210160713199
Drugs of 7 Indian pharma cos in EMA's suspension list

Questions raised over integrity of clinical research data at a site operated by GVK Biosciences BS Reporter | Hyderabad February 3, 2015 Last... ...

http://www.business-standard.com/article/companies/drugs-of-seven-indian-pharma-firms-in-ema-s-suspension-list-115020300345_1.html

Related Tags


  1. gujarat
  2. bjp
  3. india
  4. lok sabha
  5. supreme court
  6. upa
  7. bharatiya janata party
  8. congress
  9. new delhi
  10. united progressive alliance
  11. ahmedabad
  12. sonia gandhi
  13. nda
  14. rahul gandhi
  15. rajnath singh
  16. nitin gadkari
  17. delhi
  18. manmohan singh
  19. bihar
  20. national democratic alliance
  21. jd-u
  22. nitish kumar
  23. rashtriya swayamsevak sangh
  24. uttar pradesh
  25. photo
  26. advani
  27. central bureau of investigation
  28. rss
  29. janata dal-united
  30. ips

Top Coverage News


Coming to India and making

Success in manufacturing is not just about being cheap - cheap labour, cheap land, cheap power...
Broswe by: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z